The COA documents HPLC purity results, mass spectrometry confirmation of correct molecular weight, and a physical appearance inspection report
This improvement may manifest in various aspects, including increased energy levels, mood, and overall well-being
These were dose-dependent, and occurred most frequently at higher doses, and particularly during dose escalation
While the industry is poised to see broader approval of GLP-1a drugs for weight loss by the Food and Drug Administration in the near-term, our analysis shows that a large, upfront financial investment is required when treating weight loss with these drugs, said Joseph Leach, M.D., senior vice president and chief medical officer at Prime